Invokana - McKnight's Long Term Care News

Invokana

Clinical Briefs for Wednesday, October 2

Brain protein could put the brakes on Alzheimer’s … FDA approves canagliflozin (Invokana) to treat diabetic kidney disease, heart failure … More than 80% of seniors have at least one concern about telehealth … Two of this season’s four flu vaccines may be off the mark

New kind of diabetes drug gets OK

New kind of diabetes drug gets OK

The Food and Drug Administration recently approved a new kind of type 2 diabetes drug to help better control glucose levels. Invokana prevents the kidney from reabsorbing glucose, according to the FDA.

FDA approves new kind of oral diabetes drug

The Food and Drug Administration recently approved a new kind of type 2 diabetes drug to help better control glucose levels. Invokana is the first diabetes treatment approved in a new class of drugs known as sodium-glucose co-transporter 2 (SGLT2) inhibitors.

Next post in News